e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Asthma: growing understanding of influential factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety of research bronchoscopy in mild, moderate and severe asthma
E. Economidou, P. Lambrou, K. Samitas, E. Zervas, P. Karydi, A. Liapikou, S. Vittorakis, M. Gaga (Athens, Greece)
Source:
Annual Congress 2008 - Asthma: growing understanding of influential factors
Session:
Asthma: growing understanding of influential factors
Session type:
Thematic Poster Session
Number:
1146
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Economidou, P. Lambrou, K. Samitas, E. Zervas, P. Karydi, A. Liapikou, S. Vittorakis, M. Gaga (Athens, Greece). Safety of research bronchoscopy in mild, moderate and severe asthma. Eur Respir J 2008; 32: Suppl. 52, 1146
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Special problems of severe asthma in childhood
Source: Eur Respir Mon 2011; 51: 59-81
Year: 2011
Allergy in mild and severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 434s
Year: 2001
The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019
Impact of emphysema on the clinical presentation of mild to moderate COPD
Source: Annual Congress 2010 - Lung imaging
Year: 2010
Safety and feasibility of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial
Source: Annual Congress 2011 - New treatments for airway disease
Year: 2011
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Patients with asthma moderate and severe presents reduced moderate levels of physical activity, less aerobic conditioning and poorly control of the asthma
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept